about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
2.49
0.09
(3.75%)
1.8M
XNAS Volume
High volume today
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..